The solvent you use to reconstitute lyophilized (freeze-dried) peptides for research is not interchangeable. Bacteriostatic water, sterile water for injection, and sterile saline each have their own composition, shelf-life behavior, and best fit. Knowing how they differ is a practical place to start for anyone working in a research context.
What Each Solvent Contains
Sterile water for injection (SWFI) is purified water that has been sterilized. No additives, no preservatives, no dissolved salts. Because there is nothing in it but water, it works as a single-use solvent. Once a vial is opened, no preservative is present to inhibit microbial growth. SWFI is also hypotonic, and FDA-approved labeling notes that without an added solute it is not intended for direct injection, since it can cause hemolysis.
Bacteriostatic water for injection (BWI) is also sterile purified water, but it contains benzyl alcohol as a preservative. The concentration is typically 0.9% (9 mg/mL) in the common multiple-dose vials, though some products are labeled at 1.1%. FDA-approved (DailyMed) labeling describes benzyl alcohol as a well-characterized antimicrobial agent that inhibits bacterial growth. That lets a single vial be drawn from repeatedly over time, without the contamination risk that comes with plain sterile water. This multi-dose property is why BWI is the solvent most often referenced in research peptide communities.
Sterile saline, typically 0.9% sodium chloride (normal saline), adds salt to approximate the osmolarity of body fluids. It is isotonic, so it does not put osmotic stress on cells or tissues. Preservative-free sodium chloride injection is single-dose. A separate bacteriostatic sodium chloride product, also preserved with benzyl alcohol, is sold in multiple-dose form. Saline shows up across clinical and laboratory settings for a wide range of uses.
Key Differences at a Glance
| Property | Sterile Water (SWFI) | Bacteriostatic Water (BWI) | Sterile Saline (0.9% NaCl) |
|---|---|---|---|
| Preservative | None | ~0.9% benzyl alcohol (1.1% in some) | None (preserved version exists) |
| Multi-dose use | No — single use | Yes | Depends on formulation |
| Tonicity | Hypotonic | Hypotonic | Isotonic |
| Added salts | None | None | 0.9% NaCl |
| Common research use | Single reconstitution | Multi-draw peptide vials | General lab / isotonic applications |
Why the Preservative Matters
Benzyl alcohol slows or prevents bacterial growth between uses. FDA-approved labeling describes it as a bacteriostatic preservative at the concentration found in BWI, which is why the product ships in a multiple-dose container meant for repeated withdrawals. Most lyophilized peptides sold for research come in multi-mg vials that may be drawn from more than once, so bacteriostatic water gets cited in research literature and community references as the preferred reconstitution vehicle for that reason alone.
Sterile water without preservative fits when a vial will be used in a single session, or when a compound or context does not tolerate benzyl alcohol. Benzyl alcohol is specifically contraindicated for neonates. FDA-approved bacteriostatic water labeling carries a "not for use in neonates" warning, reflecting the benzyl-alcohol "gasping syndrome" first reported in the early 1980s (described in a 1982 New England Journal of Medicine report). That is one reason preservative-free sterile water stays relevant where benzyl alcohol is unsuitable.
Saline's isotonicity sometimes comes up when the reconstituted solution may contact biological materials where osmotic balance matters. The added sodium chloride can also affect the solubility of certain peptides, so research protocols differ in what they recommend.
Practical Framing for Research Contexts
Peptides sold for research are not approved for human consumption, and the choice of reconstitution solvent is a research variable, not a clinical prescription. Researchers and community references generally let solvent selection turn on a few things: whether multi-dose use is anticipated, any compound-specific compatibility notes, and the intended downstream assay or application.
No single one of these is inherently "better" in the abstract. The right choice depends on context. Published pharmaceutical standards (USP, for example) define quality specifications for each of these water-for-injection products, and sourcing from suppliers who meet those standards is a baseline research practice.
Sources
- DailyMed (NLM/FDA) — Bacteriostatic Water for Injection label
- Pfizer Medical — Bacteriostatic Water for Injection, USP description
- Drugs.com — Water for Injection (SWFI) prescribing information
- New England Journal of Medicine (1982) — The Gasping Syndrome and Benzyl Alcohol Poisoning
- USP (United States Pharmacopeia) — Water for Injection standards
- Finnrick — Independent peptide testing references